These include: More than $150 million to the PATH Malaria Vaccine Initiative to advance development of next-generation malaria vaccines; and $29 million to the Clinton Health Access Initiative to support malaria elimination efforts in Southern Africa and the Greater Mekong Sub-region of Southeast Asia.